Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

UTI ENERGY, INC. (NASDAQ:PTEN) today reported that for the month of March 2025, the Company had an average of 106 drilling rigs operating in the United States. For the three months ended ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Urinary Tract Infection UTI is a bacterial infection that commonly affects women particularly menopausal women An expert ...

An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

Sysmex’s PA-100 AST System is redefining the standard of care for diagnosing and treating uncomplicated urinary tract ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...